2-[1-(2-Nitro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid 2-chloro-ethyl ester | 62760-01-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 2-[1-(2-Nitro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid 2-chloro-ethyl ester
• 英文别名: 2-Chloroethyl 2-[(2-nitrophenyl)methylidene]-3-oxobutanoate
• CAS: 62760-01-4
• 化学式: C₁₃H₁₂ClNO₅
• 分子量: 297.695
• InChiKey: MHSXTMIKGZNWFF-UHFFFAOYSA-N

物化性质

• 沸点：
  456.7±45.0 °C(Predicted)
• 密度：
  1.352±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  89.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-[1-(2-Nitro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid 2-chloro-ethyl ester 以 异丙醇 为溶剂， 反应 3.0h， 生成 5-O-[2-[3,3-diphenylpropyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
  参考文献：
  名称：

  Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity

  摘要：

  A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenyl-propylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4-dihydropyridines binding site labelled by H-3-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375-lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries. (C) Elsevier, Paris.

  DOI：

  10.1016/s0223-5234(98)80015-9
• 作为产物：
  描述：

  2-乙酰基乙酸氯乙酯 、 邻硝基苯甲醛 在 盐酸 作用下， 以 甲苯 为溶剂， 以58%的产率得到2-[1-(2-Nitro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid 2-chloro-ethyl ester
  参考文献：
  名称：

  Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity

  摘要：

  A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenyl-propylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4-dihydropyridines binding site labelled by H-3-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375-lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries. (C) Elsevier, Paris.

  DOI：

  10.1016/s0223-5234(98)80015-9

文献信息

• Agents for the Treatment of Overactive Detrusor. I. Synthesis and Structure-Activity Relationships of 1,1'-Biphenyl Derivatives.
  作者：Kazuhiko TAKE、Kazuo OKUMURA、Koichi TAKIMOTO、Masayuki KATO、Minoru OHTSUKA、Youichi SHIOKAWA

  DOI：10.1248/cpb.39.2915

  日期：——

  A series of 1, 1'-biphenyl-2, 6-dicarboxylic acid diesters were synthesized and examined for their inhibitory activity on guinea-pig detrusor muscle contraction at electrical field stimulation in vitro. Among them, 6-isopropyl 2-methyl 3-hydroxy-5-methyl-2'-nitro-(1, 1'-biphenyl)-2, 6-dicarboxylate, FR75513 (8a) was one of the potent compounds (IC50=3.3×10-6 g/ml). This compound (8a) exhibited a strong inhibitory activity on detrusor contraction after intravenous administration in anesthetized rats (ID50=0.04 mg/kg).

  研究人员合成了一系列 1，1'-联苯-2，6-二羧酸二酯，并考察了它们在体外电场刺激下对豚鼠逼尿肌收缩的抑制活性。其中，2-甲基-3-羟基-5-甲基-2'-硝基-(1, 1'- 联苯)-2, 6-二甲酸 6-异丙酯，FR75513（8a）是强效化合物之一（IC50=3.3×10-6 g/ml）。麻醉大鼠静脉注射该化合物（8a）后，其对逼尿肌收缩有很强的抑制作用（ID50=0.04 mg/kg）。
• 6-Acyloryalkyl-1,4-dihydropyridine derivatives and a method of effecting
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04145432A1

  公开（公告）日：1979-03-20

  This invention relates to 1,4-dihydropyridine derivatives. More particularly, it relates to new 1,4-dihydropyridine derivatives thereof which have vasodilating and anti-hypertensive activity, to processes for the preparation thereof, and to pharmaceutical composition comprising the same for therapeutical treatment in cardiovascular diseases and hypertension in human being.

  本发明涉及1,4-二氢吡啶衍生物，更具体地，涉及具有血管扩张和降压活性的新型1,4-二氢吡啶衍生物，其制备方法以及包含它们的制药组合物，用于治疗人类心血管疾病和高血压。
• Certain 4-aryl-1,4-dihydro-3,5-pyridinedicarboxylates having
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04525478A1

  公开（公告）日：1985-06-25

  1,4-Dihydropyridine derivatives of the general formula ##STR1## having vasodilating and anti-hypertensive activity, processes for preparing same, and pharmaceutical compositions thereof for treating cardiovascular diseases.

  具有扩血管和降压活性的一般式为##STR1##的1,4-二氢吡啶衍生物，其制备方法以及用于治疗心血管疾病的制药组合物。
• 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04284634A1

  公开（公告）日：1981-08-18

  1,4-dihydropyridine derivatives of the general formula ##STR1## having vasodilating and anti-hypertensive activity, processes for preparing same, and pharmaceutical compositions thereof for treating cardiovascular diseases.

  具有扩血管和降压活性的1,4-二氢吡啶衍生物，其一般式为##STR1##，制备方法以及用于治疗心血管疾病的制药组合物。
• 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04338322A1

  公开（公告）日：1982-07-06

  This invention relates to 2-or 6-cyano or cyano(lower)alkyl-4-phenyl or (substituted phenyl)1,4-dihydropyridine-3,5-dicarboxylates and derivatives which have vasodilating and hypertensive activity, processes for their preparation, pharmaceutical compositions for containing same and for methods of treating hypertension and cardiovascular diseases.

  本发明涉及2-或6-氰基或氰基（较低）烷基-4-苯基或（取代苯基）1,4-二氢吡啶-3,5-二羧酸酯及其衍生物，其具有扩血管和降压活性，其制备方法，含有它们的制药组合物和治疗高血压和心血管疾病的方法。